List of experts involved

  • Wim van den Brink - Chair of the board

    Why do I work for ICASA?
    I am involved in ICASA because I have seen the damage that addiction can cause to the patient, his or her family and to society as a whole and the important role that genetics and developmental problems seem to play in the onset and course of addiction. Some 20 years ago, I started my career as an addiction researcher. During this 20 years it became obvious that addiction is not a choice or a question of weak will, but a serious disease with genetic and developmental roots. One of the most prominant factors in the development of addiction turned out to be ADHD. Since that is known, preventing and treating ADHD should be one of our main goals. ICASA provides the ideal network to make this possible. Working with a group of dedicated researchers and clinicians, contributes on the development and execution of new and exciting studies to solve at least some pieces of the puzzle. It has been a great and very rewarding experience so far.

    Working experience
    1952 born in Hilversum, The Netherlands
    1981 MD degree from the Vrije Universiteit van Amsterdam, Amsterdam, The Netherlands
    1986 fellowship Psychiatric Epidemiology Columbia University New York, USA
    1989 PhD degree from the State University of Groningen, The Netherlands (Diagnosis of personality Disorders)
    1992 professor of Psychiatry and Addiction, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    1993 director Amsterdam Institute for Addiction research (AIAR)
    1996 scientific director National Committee on the Treatment of Heroin Addicts (CCBH)
    2002 president of the European Association of Substance Abuse Research (EASAR)
    2005 Chair International Collaboration of ADHD and Susbtance Abuse (ICASA)
    2006 Associate Editor Drug and Alcohol Dependence (DAD)
    2006 Editor European Addiction Research (EAR)
    2010 Executive member of European College of Neuropsychopharmacology (ECNP)

  • Geurt van de Glind - Trimbos-instituut, The Netherlands

    Why do I work for ICASA?
    ADHD and Substance Use Disorders are both highly controversial. Meanwhile thousands of patients are suffering from both disorders, and also thousands of children and adolescents with ADHD are on their way developing substance abuse problems. The only way for gaining reliable knowledge is high quality research. Working for ICASA means working on high quality research for finding answers and maybe solutions. I want to contribute to these answers and solutions.  

    Working experiences
    I worked as a mental health nurse 13 years in an addiction treatment center in the Netherlands. After graduating for the masters degree in Healt Sciences in 2000 I started working for the Trimbos-instituut, Netherlands institute on mental health and addiction. At the Trimbos-institute I worked on numerous projects. One of these was the development of a protocol for professionals in addiction treatment centers for diagnosing and treating patients who, apart from their substance dependence, also had ADHD.
    This project made me initiating the international collaboration on this topic. Ever since this international research group in December 2005 met for the first time, I worked on this issue.
    Currently I am coordinating the first collaborative project of ICASA, the International ADHD in Substance use disorders Prevalence (IASP) study.

  • Arvid Skutle - Bergen Clinics Foundation, Norway

    Why do I work for ICASA?
    From my 30 years in the addiction field, as clinician and researcher, I am pleased by the increasing focus on comorbid conditions, including ADHD, that many of our patients suffer from. Successful treatment of the substance abuse requires reliable and valid assessment of the ADHD, followed by knowledge-based treatment methods. The ICASA network with its research projects gives us an opportunity to reach these very important goals.  

    Working experiences
    I started my career as psychologist in the addiction field in 1980, before I became associate professor at the Department of Community Psychology at the University of Bergen in 1985. Some years later I took over the position as head of the Department of Psycho-Social Science. Prevention and treatment of addiction problems have always been my main professional areas, in research as well as in treatment and prevention. For more than a decade I have been the head of the Research Unit at the Bergen Clinics Foundation. We are currently working with a number of clinical relevant research projects, including the IASP study.

  • Josep Antoni Ramos-Quiroga - Hospital Universitari Vall d'Hebron, Spain

    Why do I work for ICASA?
    In my clinical practice, daily I visit adult ADHD patients that developed Substance Use Disorders at early adolescence, but never received a diagnostis of ADHD at childhood. One of my targets is increase the knowledge of ADHD plus Substance Use Disorders, in terms of etiology , diagnostic process and treatment. Working for ICASA is a great opportunity to improve the high quality research in this topic.  

    Working experiences
    J. Antoni Ramos-Quiroga, MD, PhD, (1971) is Associate Professor of Psychiatry at the Universitat Autònoma de Barcelona and Coordinator of ADHD Program of the Department of Psychiatry at Hospital Universitari Vall d’Hebron in Barcelona, Spain.
    In 2002, Dr. Ramos-Quiroga began as coordinator of the ADHD Program at Hospital Universitari Vall d’Hebron in Barcelona, Spain. He is author of several international publications and books on adult ADHD. He is involved in adult ADHD research, including clinical studies, pharmacological trials, neuroimaging studies and genetics. He is co-organizer of the Adult ADHD Theorical-practical Curses of the Hospital Universitari Vall d’Hebron (this year the 12th edition). He is a member of the “European Network Adult ADHD”, the “International Multicentre Persistent ADHD CollaboraTion” (focus on adult ADHD and genetics). He is member of the Scientific Committee of ADANA Foundation and the Tourette Foundation in Spain.

  • Maija Konstenius - Karolinska University Hospital

     

    Why do I work for ICASA?
    In my clinical work with patients with Substance Use Disorders I meet many patients who also have ADHD – often unrecognized. Understanding and recognizing both conditions is the basis of good treatment and ICASA provides an excellent framework for international collaboration on this important topic. I firmly believe that our joint efforts will contribute to more knowledge and better understanding of the mechanisms. The question of ADHD co-occurring in patients with Substance Use Disorders is intriguing and clinically highly relevant.

    Working experiences.
    For the last 18 years I have worked as a clinical psychologist at an addiction treatment clinic in Stockholm, Sweden and the past ten years I have been involved in several projects concerning diagnosis and treatment of patients with ADHD and Substance Use Disorders. I am part of a research group led by Professor Johan Franck at Karolinska Institutet, Sweden. Our group has its main focus on clinical trials of novel psychopharmacological treatments for addiction. I am currently coordinating the Swedish participation in the IASP study.

  • Sharlene Kaye - National Drug and Alcohol Research Centre, Australia

    Why do I work for ICASA?
    Over the years that I have been working with people with Substance Use Disorders, it has become clear that there is usually more to alcohol and drug addiction than the addiction itself. There are many psychological issues that may precede and/or result from Substance Use Disorders. ADHD is a disorder that makes life more difficult, in an already complicated world, for the developing child and adolescent, particularly if it goes undiagnosed. When Substance Use Disorders develop in people with ADHD, both disorders are complicated even further. Working for ICASA provides the opportunity to conduct important and innovative research with a team of international experts in these fields, and to contribute to a better understanding of the relationship between these disorders. 
     

    Working experiences
    I have spent the past 16 years working in the area of illicit drug research at the National Drug and Alcohol Research Centre (NDARC), a research institute within the Faculty of Medicine at the University of New South Wales in Sydney, Australia. My particular area of expertise is the physical and psychological harms associated with the use of psychostimulant drugs. Since joining NDARC in 1994, I have worked on several research projects, including a major study of Antisocial Personality Disorder among injecting drug users. I completed my PhD at NDARC in 2003, which examined the patterns and harms of cocaine use. More recently, I have worked on studies examining fatal and non-fatal cocaine overdose, psychostimulant-related deaths across Australia, and a project examining organic brain damage following opioid overdose. I am currently investigating the diversion and misuse of stimulant medication for ADHD among illicit psychostimulant users.

The ICASA Network

kaartje
> View map